机器人保脾全胃切除术对比腹腔镜手术显示更好的短期优势
该回顾性研究比较了机器人与腹腔镜全胃切除联合保脾脾门淋巴结清扫的围手术期短期结局。经倾向性评分匹配后,机器人组在脾动脉干区域清扫时间、出血量及术中技术错误次数上均显著低于腹腔镜组,且术后下床、排气和进食时间更优,两组脾切除率及30天并发症和死亡率无显著差异。
要点
- 机器人保脾脾门淋巴结清扫的脾动脉干区域清扫时间、出血量和术中技术错误次数均显著低于腹腔镜。
- 机器人组No.11d淋巴结清扫率更高,术后下床、排气和进食时间更短。
- 两组脾切除率及术后30天并发症和死亡率无显著差异。
核心结论
- 与腹腔镜保脾脾门淋巴结清扫相比,机器人手术在手术质量和术后恢复方面更具优势,且并发症和死亡率相似。
研究设计与样本
- 回顾性分析2016年7月至2020年12月115例机器人全胃切除联合机器人保脾脾门淋巴结清扫(RSPSHL)和697例腹腔镜全胃切除联合腹腔镜保脾脾门淋巴结清扫(LSPSHL)患者的临床病理资料,采用1:2倾向性评分匹配(PSM)平衡组间差异。
主要发现
- PSM后RSPSHL组115例与LSPSHL组230例基线特征均衡。
- RSPSHL组脾动脉干区域清扫时间(5.4 ± 1.9 min vs. 7.8 ± 3.6 min,P < 0.001)、SPSHL期间估计出血量(9.6 ± 4.8 ml vs. 14.9 ± 7.8 ml,P < 0.001)及SPSHL期间平均术中技术错误次数(15.1 ± 3.4 次/例 vs. 20.7 ± 4.3 次/例,P < 0.001)均显著低于LSPSHL组。
- RSPSHL组No.10淋巴结清扫率(78.3% vs. 70.0%,P = 0.104)和No.11d淋巴结清扫率(54.8% vs. 40.4%,P = 0.012)更高,术后下床、首次排气和首次进食时间显著改善(P < 0.05)。
- 两组脾切除率相似(1.7% vs. 0.4%,P = 0.539),术后30天内并发症和死亡率无显著差异(13.0% vs. 15.2%,P = 0.589)。
临床怎么用
- 对于复杂的保脾脾门淋巴结清扫,机器人手术可能为更好选择,可考虑用于全胃切除术中需行该清扫的患者。
局限性
- 本研究为回顾性分析,可能存在选择偏倚;样本来自单中心,结论需前瞻性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Robotic surgery may be advantageous for complex surgery. We aimed to compare the intraoperative and postoperative short-term outcomes of spleen-preserving splenic hilar lymphadenectomy (SPSHL) during robotic and laparoscopic total gastrectomy. METHODS: From July 2016 to December 2020, the clinicopathological data of 115 patients who underwent robotic total gastrectomy combined with robotic SPSHL (RSPSHL) and 697 patients who underwent laparoscopic total gastrectomy combined with laparoscopic SPSHL (LSPSHL) were retrospectively analyzed. A 1:2 ratio propensity score matching (PSM) was used to balance the differences between the two groups to compare their outcomes. The Generic Error Rating Tool was used to evaluate the technical performance. RESULTS: After PSM, the baseline preoperative characteristics of the 115 patients in the RSPSHL and 230 patients in the LSPSHL groups were balanced. The dissection time of the region of the splenic artery trunk (5.4 ± 1.9 min vs. 7.8 ± 3.6 min, P < 0.001), the estimated blood loss during SPSHL (9.6 ± 4.8 ml vs. 14.9 ± 7.8 ml, P < 0.001), and the average number of intraoperative technical errors during SPSHL (15.1 ± 3.4 times/case vs. 20.7 ± 4.3 times/case, P < 0.001) were significantly lower in the RSPSHL group than in the LSPSHL group. The RSPSHL group showed higher dissection rates of No. 10 (78.3% vs. 70.0%, P = 0.104) and No. 11d (54.8% vs. 40.4%, P = 0.012) lymph nodes and significantly improved postoperative recovery results in terms of times to ambulation, first flatus, and first intake (P < 0.05). The splenectomy rates of the two groups were similar (1.7% vs. 0.4%, P = 0.539), and there was no significant difference in morbidity and mortality within postoperative 30 days (13.0% vs. 15.2%, P = 0.589). CONCLUSION: Compared to LSPSHL, RSPSHL has more advantages in terms of surgical qualities and postoperative recovery process with similar morbidity and mortality. For complex SPSHL, robotic surgery may be a better choice.
引用
- Wang ZK, Lin JX, Wang FH, et al. Robotic spleen-preserving total gastrectomy shows better short-term advantages: a comparative study with laparoscopic surgery. Surg Endosc. 2022. PMID: 35697854. doi:10.1007/s00464-022-09352-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。